Tag: beigene

November 10, 2016

BeiGene Reports Third Quarter 2016 Financial Results

BeiGene, a clinical-stage biopharmaceutical company developing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today reported business highlights...
February 24, 2016

5 February IPOs on the NASDAQ

This month, investors can expect some new blood to enter the life science market, with five companies — Editas Medicine,...